Lux Biosciences Names Paul Chaney, Former President (OSI) Eyetech and EVP OSI Pharmaceuticals, Inc., to Board of Directors

JERSEY CITY, N.J.--(BUSINESS WIRE)--Lux Biosciences today announced the appointment of Paul G. Chaney to the company’s board of directors. Mr. Chaney is the former President of (OSI) Eyetech and Executive Vice President of OSI Pharmaceuticals.